The whole company currently only has a market capitalisation of $20m. It seems to me that just the veterinary market alone for a unique product like this that will make vaccinating large herds of animals faster, safer, easier and a lot more cost efficient. It would be worth a whole lot more than $20m to a large pharmaceutical co who could charge premium prices for such a unique product imo.
There now seems to be no impediment to it's use on animals.
Then there is the possibility of the human market....
- Forums
- ASX - By Stock
- NAL
- needle free injection vaccine breakthrough
needle free injection vaccine breakthrough, page-11
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online